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Host restriction of vaccinia virus has been previously described in CHO and RK13 cells in which a cowpox virus CP77 gene rescues
vaccinia virus growth at the viral protein translation level. Here we investigate the restrictive stage of vaccinia virus in HeLa cells using a
vaccinia mutant virus (VV-hr) that contains a deletion of 18-kb genome sequences resulting in no growth in HeLa cells. Insertion of CP77
gene into VV-hr generated a recombinant virus (VV-36hr) that multiplied well in HeLa cells. Both viruses could enter cells, initiate viral
DNA replication and intermediate gene transcription. However, translation of viral intermediate gene was only detected in cells infected with
VV-36hr, indicating that CP77 relieves host restriction at the intermediate gene translation stage in HeLa cells.
Caspase-2 and -3 activation was observed in HeLa cells infected with VV-hr coupled with dramatic morphological alterations and
cleavage of the translation initiation factor eIF4G. Caspase activation was reduced in HeLa cells infected with VV-36hr, indicating that CP77
acts upstream of caspase activation. Enhanced phosphorylation of PKR and eIF2a was also observed in cells infected with VV-hr and was
suppressed by CP77. Suppression of eIF4G cleavage with the caspase inhibitor ZVAD did not rescue virus translation, whereas expression of
a mutant eIF2a protein with an alanine substitution of serine at amino acid position 51 (eIF2aS51A) partially restored viral translation and
moderately increased virus growth in HeLa cells.
D 2004 Elsevier Inc. All rights reserved.
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Poxviruses are known to encode diverse viral molecules
that modulate host cell responses to suit the viral needs.
However, in some cell types, poxviruses fail to complete
their cycle, a phenomenon known as host restriction (Drillien
et al., 1981, 1978; Fenner and Sambrook, 1966; Gemmell
and Fenner, 1960; Hruby et al., 1980; McClain, 1965;
Somogyi et al., 1993; Tagaya et al., 1961; Wyatt et al., 1998).
Previous studies of mutant viruses have identified viral host
range (hr) genes that rescue virus growth in otherwise0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.07.032
* Corresponding author. Institute of Molecular Biology, Academia
Sinica, #128, Sec. 2, Academia Road, Nankang, Taipei 115, Taiwan, ROC.
Fax: +886 2 27882253.
E-mail address: mbwen@ccvax.sinica.edu.tw (W. Chang).restrictive cells. Cowpox virus expresses a hr protein,
namely CP77 or CHOhr, that is encoded by the V025 gene,
allowing virus growth in CHO cells, whereas a V025
orthologue in vaccinia virus is dysfunctional due to multiple
mutations (Goebel et al., 1990; Kotwal and Moss, 1988;
Perkus et al., 1990; Shchelkunov et al., 1998; Spehner et al.,
1988). Vaccinia virus contains two hr genes, K1L and C7L,
which allow virus multiplication in RK13 and human cells
(Gillard et al., 1986; Perkus et al., 1990; Sutter et al., 1994).
The vaccinia E3L gene supports virus growth in HeLa, Vero,
and L929 cells (Beattie et al., 1996; Chang et al., 1995). The
SPI-1 genes in rabbitpox and vaccinia virus are required for
replication in A549, PK-15, and human keratinocytes (Ali et
al., 1994; Shisler et al., 1999). In addition to the orthopoxvi-
rus genes named above, myxoma virus, which belongs to the
leporipoxvirus genus, also contains host range genes (M-T2,04) 199–212
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RL-5 cells and rabbit leukocytes (Barry et al., 1997; Macen
et al., 1996; Mossman et al., 1996). The multiplication of
fowlpox, penguinpox virus, and even vaccinia virus in
heterologous host cells is also known to be restricted under
circumstances for which no particular hr gene has yet been
identified (Li et al., 1998; Somogyi et al., 1993; Stannard et
al., 1998). Nevertheless, poxviruses have clearly evolved an
array of hr genes to ensure virus growth in a cell-type-
specific or species-specific manner.
Up to now, the cellular mechanism of host restriction
remains elusive. Although apoptotic suppression is fre-
quently associated with expression of viral hr genes in the
restrictive cells, the nature of such an association is largely
unknown (for review, see McFadden and Barry, 1998 and
the references therein). One of the exceptions is vaccinia
E3L, which binds to double-stranded RNA and down-
regulates PKR-mediated apoptosis (Davies et al., 1993;
Xiang et al., 2002). Another example is vaccinia K1L,
which is required for activation of a host-encoded inter-
mediate transcription factor in RK13 cells although the
precise interactions involved remain to be elucidated (Sutter
et al., 1994). A third example is myxoma M11L, which was
recently shown to prevent the release of mitochondrial
cytochrome c induced by staurosporine (Everett and
McFadden, 2001a, 2001b; Everett et al., 2000, 2002).
Host restriction of vaccinia virus in CHO, RK13, and
human MRC-5 cells was thought to be regulated by a
conserved cellular pathway, because the cowpox CP77
protein is capable of rescuing host restriction imposed by
deletion of vaccinia virus C7L and K1L genes (Perkus et al.,
1990; Ramsey-Ewing and Moss, 1996). However, these
three genes are not functionally equivalent as neither C7L
nor K1L can rescue host restriction in the absence of CP77
expression in CHO cells (Spehner et al., 1988). Similarly,
C7L does not complement the K1L gene defect in RK13
cells (Perkus et al., 1990). The nature of the functional
hierarchy among CP77, K1L, and C7L genes is not known
and there is no obvious sequence homology among these
three genes (Goebel et al., 1990; Oguiura et al., 1993;
Spehner et al., 1988).
Vaccinia virus growth in CHO, RK13, and human cells
has been previously investigated. CHO cells were restrictive
for viral intermediate gene translation (Ramsey-Ewing and
Moss, 1998). Concurrently, significant DNA laddering and
apoptotic bodies were induced in restrictive CHO cells (Bair
et al., 1996; Ink et al., 1995). In these cells, expression of
viral CP77hr gene partially suppressed apoptosis; however,
this may simply reflect an indirect influence of the hr gene
on the cellular response, as expression of anti-apoptotic
molecules alone, such as E1B and bcl-2, did not rescue virus
growth (Chung et al., 1997; Ink et al., 1995). RK13 cells,
however, restrict a vaccinia K1L-mutant virus at the early
gene translation stage and only minor apoptotic features
have been detected in these cells (Chung et al., 1997;
Ramsey-Ewing and Moss, 1995, 1996, 1998). Moreover,apoptotic modulation by bcl-2 in RK13 cells did not
interfere with virus growth (Chung et al., 1997). In human
KB and Hep2 cells, a vaccinia hr mutant was restricted at an
early stage of infection before viral DNA replication
(Drillien et al., 1981). However, apoptotic events, if
triggered, were not investigated in these human cells
(Drillien et al., 1981; Gillard et al., 1985, 1986).
In summary, prior studies of host restriction suggested
that hr genes possess anti-apoptotic activity that antagonizes
host restriction, whereas other studies have implied that
apoptosis is the ultimate cellular stress response associated
with host restriction. In this study, we used a mutant virus
VV-hr to identify its restrictive stage in human HeLa cells.
VV-hr, has an 18-kbp deletion of the viral genome that
overlaps two hr genes, K1L and C7L, known to be essential
for VV multiplication in various human cell lines (Drillien
et al., 1981). We also overexpressed CP77 in VV-hr to study
the role of CP77 gene in host range regulation. Furthermore,
we investigated cellular proteins that are affected by virus
infection in HeLa cells to identify cellular molecules that
mediate vaccinia virus host restriction.Results
Without CP77, growth of VV-hr is blocked at the stage of
viral intermediate gene translation in HeLa cells
The restrictive stage of VV-hr in HeLa cells was studied
as compared to a recombinant virus, VV-36hr, in which the
cowpox virus CP77 gene was inserted into the tk locus of
VV-hr. HeLa cells were infected with VV-hr or VV-36hr at a
MOI of 5 PFU per cell and the cell lysates were harvested for
virus titrations. As shown in Fig. 1A, no increase in titer of
VV-hr was detected in the one-step growth analysis, whereas
the titer of VV-36hr increased up to 100-fold. Thus, as
expected, growth of VV-hr was restricted in HeLa cells and
expression of CP77 from VV-36hr rescued host restriction.
To determine whether viral proteins are synthesized in
HeLa cells infected with VV-hr, we infected HeLa cells with
VV-hr and VV-36hr and monitored viral protein synthesis
with 35S-methionine labeling at different times post infec-
tion (p.i.) (Fig. 1B). In HeLa cells infected with VV-hr, host
protein synthesis was completely inhibited within 4–6 h p.i.,
with only early transient detection of several viral proteins at
1–3 h p.i. but not at 4–8 h p.i. In cells infected with VV-
36hr, cellular protein synthesis was also shut off; however,
abundant viral protein synthesis was detected and continued
into the late stage at 8 h p.i. Therefore, host restriction of
VV-hr resulted in a defect in late viral protein synthesis in
the infected cells.
We next investigated whether the lack of late viral
protein synthesis in VV-hr was due to an indirect
consequence of an earlier blockage of viral DNA repli-
cation because gene expression in poxviruses is regulated
in a cascade manner. HeLa cells were infected with VV-hr
Fig. 1. Host restriction of VV-hr and VV-36hr in HeLa cells. (A) Virus growth analysis of VV-hr and VV-36hr in HeLa cells. HeLa cells were infected with VV-
hr or VV-36hr at a MOI of 5 PFU per cell and cell lysates were harvested at 0 and 24 h p.i. as indicated at the bottom of the figure. The experiments were
repeated three times and virus titers in the cell lysates were determined by plaque assays on BHK21 cells as described in Materials and methods. (B) 35S-
methionine labeling experiments for viral protein synthesis. HeLa cells were infected as described in A and pulsed for 60 min in 35S-methionine-containing
medium at various times as indicated. Cells were then harvested immediately and analyzed on 10% SDS-PAGE. The asterisks * mark the diagnostic cellular
protein bands for monitoring protein shut-off. (C). Dot blot analysis of viral DNA synthesis in the infected cells. HeLa cells were infected as described in A and
harvested at different times p.i. Viral DNA was extracted and aliquots were applied to nitrocellulose filters and hybridized with a 32P-labeled VGF DNA
fragment, washed, and autoradiographed. A typical blot is shown here. (D) Quantitation analysis of viral DNA synthesis in the infected cells. The nitrocellulose
filter as shown in C was scanned with a PhosphoImager and quantitated by computer program analysis as described by the manufacturer (Molecular
Dynamics). The experiments were performed twice, and the resulting blots were scanned, quantitated, and averaged with a phosphoimager (Molecular
Dynamics, Inc.). A summary of results shown here is illustrated in the box at the right hand of panel D.
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different times p.i. The amounts of viral DNA were
monitored by dot blot analyses, as shown in Fig. 1C.
Significant increases in viral DNA were detected in cells
infected with VV-hr and VV-36hr as early as 1 h p.i.,
indicating that active viral DNA replication had beeninitiated at this time. Quantification of the DNA-impreg-
nated filters revealed that the kinetics of VV-hr DNA
synthesis is similar to that of VV-36hr (Fig. 1D). As viral
DNA replication occurred in HeLa cells infected with VV-
hr and VV-36hr, host restriction of VV-hr must have
occurred after this step.
Fig. 2. CP77 regulates translation of the intermediate G8R gene in HeLa
cells. (A) Expression of intermediate G8R RNA in the infected cells. HeLa
cells were infected as described in Fig. 1, and total RNA was isolated at
various times for Northern blot analyses with a32P-labeled G8R DNA
fragment. The blot was washed and autoradiographed. The two black marks
next to the blot indicate the positions of 28 S and 18 S rRNA, respectively.
(B) Expression of intermediate G8R protein expressed in the infected cells.
HeLa cells were infected and cell lysates were harvested at various times,
separated on SDS-PAGE, and transferred for immunoblot analysis with an
anti-G8R antibody. (C) Expression of late viral F17R RNA in the infected
cells. The blot in A was stripped and rehybridized with a 32P-labeled F17R
DNA fragment, washed again, and autoradiographed. (D) Expression of late
F17R protein in the infected cells. The cell lysates used in B were also used
for immunoblot analysis with an Ab recognizing F17R protein. The
summary of results shown in Fig. 2 is illustrated in the box on the right
hand.
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ate gene expression from the viral genome (Keck et al.,
1990; Vos and Stunnenberg, 1988). We therefore moni-
tored transcription of the intermediate viral gene, G8L, in
cells infected with VV-hr and VV-36hr to determine
whether host restriction of VV-hr occurs at this stage.
Northern blot analyses were performed with total RNA
isolated from HeLa cells infected with VV-hr or VV-36hr
and hybridized with a 32P-labeled DNA probe derived
from G8R gene sequences (Fig. 2A). The size of G8R
transcripts is heterogeneous, ranging from 0.8 to 4.5 kb,
due to the lack of a specific transcription termination signal
at the 3V end (Baldick and Moss, 1993; Wright et al.,
1991). G8R RNA transcripts were detected in cells infected
by both VV-hr and VV-36hr as early as 2 h p.i., revealingthat there was no blockage of viral intermediate gene
transcription in VV-hr.
To determine if intermediate G8R RNA is translated into
protein, cell lysates were prepared from HeLa cells infected
with VV-hr or VV-36hr for immunoblot analyses with an
antiserum recognizing the G8R protein (Fig. 2B). In contrast
to the Northern blot analysis, the G8R protein was detected
in cells infected with VV-36hr but not with VV-hr at 2–8 h
p.i. These results demonstrated that translation of the viral
intermediate gene, G8R, was blocked in HeLa cells infected
with VV-hr.
Because intermediate proteins such as A1L, A2L, and
G8R serve as transcription factors for late viral genes, it is
expected that the lack of the G8R protein in cells infected with
VV-hr would not allow transcription or translation of late
viral genes to proceed (Keck et al., 1993; Passarelli et al.,
1996; Wright et al., 1991). The transcription of a viral late
F17R gene, which encodes a major late transcript of 1.5 kb in
size, was monitored in cells infected with VV-hr or VV-36hr.
Northern blots only detected the F17R transcript in cells
infected with VV-36hr but not with VV-hr (Fig. 2C).
Consequently, the F17R protein was detected in cells infected
with VV-36hr but not in cells infected with VV-hr (Fig. 2D).
In summary, the above results revealed that host cell
restriction of VV-hr virus growth in HeLa cells occurs at the
stage of intermediate gene translation and that the CP77
gene rescues the viral translation defect.
Apoptosis occurred in HeLa cells infected with VV-hr after
viral DNA replication and was delayed/suppressed by CP77
expression
HeLa cells infected with VV-hr or VV-36hr developed
different morphological changes (Fig. 3). VV-36hr infection
resulted in cell rounding and slow detachment (Fig. 3C);
however, VV-hr infection induced dramatic morphological
shrinkage of the infected cells (Fig. 3B). Membrane
blebbing and cell shrinkage have been described as
indicative of cytoskeleton rearrangement due to apoptosis,
implying that apoptosis of HeLa cells occurred after VV-hr
infection (Coleman et al., 2001; Mills et al., 1998; Sebbagh
et al., 2001). Cell rounding, in contrast, is a typical necrotic
response commonly described in the productive infection of
vaccinia virus. To determine how far the virus life cycle
needs to proceed before such distinct apoptotic morphology
was triggered, we treated HeLa cells during virus infection
with cordecepin (CP), cycloheximide (CHX), and cytosine
arabinoside (araC) to block early viral transcription, early
translation, and DNA replication, respectively (Person and
Beaud, 1978). All three chemicals inhibited cellular
shrinkage and reversed cells to an attached phenotype,
indicating that viral DNA replication is necessary to trigger
shrinkage of HeLa cells infected with VV-hr (Fig. 3D,F,H).
All three chemicals also inhibited cell rounding in cells
infected with VV-36hr (Fig. 3E,G,I). Cell shrinkage was
inhibited when VV-hr-infected cells were incubated with 50
Fig. 4. Caspase activation in HeLa cells infected with VV-hr and VV-36hr.
HeLa cells were infected with VV-hr or VV-36hr at a MOI of 5 PFU per
cell. Cell lysates were harvested at 8 h p.i. and used in caspase activity
assays with fluorogenic substrates for caspase -1, -2, -3, -8, and -9, as
described in Materials and methods. The experiments were repeated three
times. Fluorescence intensities representing activation of caspases were
measured with a spectrofluorometer, using an excitation wavelength of 360
nm and an emission wavelength of 460 nm. The folds induction of caspase
activity shown in the Y-axis represents the ratio of caspase activity detected
in cells infected with VV-hr or VV-36hr to the activity detected in the mock
cells.
Fig. 3. The apoptotic morphology of HeLa cells infected with VV-hr
depends on continuation of the viral life cycle beyond DNA replication.
HeLa cells were mock-infected (A) or infected with VV-hr (B, D, F, and H)
or VV-36hr (C, E, G, and I) in the absence (B and C) or in the presence of
CP (40 Ag/ml) (D, E), CHX (100 Ag/ml) (F, G) or araC (40 Ag/ml) (H, I)
and photographed at 8 h p.i.
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cell shrinkage (data not shown).
To demonstrate that apoptosis was indeed triggered in
HeLa cells infected with VV-hr, we initially isolated
cellular genomic DNA from cells infected with VV-hr or
VV-36hr to examine whether nuclear DNA is degraded in
these cells. However, we did not detect DNA laddering by
agarose gel analysis at 8 h p.i. (data not shown). As DNA
fragmentation represents a late apoptotic event, we directly
measured caspase activity in cell lysates. Increased
activities of caspase-2 and -3, but not caspase -1, -8, and
J.-C. Hsiao et al. / Virology 329 (2004) 199–212204-9, were detected in HeLa cells infected with VV-hr at 8 h
p.i. (Fig. 4). Actually, we could detect caspase-2 and -3
activities as early as 4 h p.i. but the activities accumulated
higher at 8 h p.i. (data not shown). Both caspase activities
were reduced in HeLa cells infected with VV-36hr,
indicating that CP77 delayed or suppressed caspase
activation (Fig. 4).
Caspase-dependent cleavage of eIF4G and increased
phosphorylation of eIF2a and PKR were observed in HeLa
cells infected with VV-hr
The above results altogether indicated that shutdown of
host protein synthesis occurred in HeLa cells infected with
VV-hr and VV-36hr whereas blockage of viral translation
only occurred in apoptotic cells infected with VV-hr. We
thus investigated if apoptosis has a direct impact on
translation factors.
In mammalian cells, translation initiation requires multi-
ple translation initiation factors (eIFs). For example, eIF2aFig. 5. (A) Cleavage of eIF4G in HeLa cells infected with VV-hr and VV-36hr. H
times as indicated at the top of the figure. Lysates were separated on a 7% SDS-PAG
indicate the positions of the intact eIF4G and the arrowheads indicate the 100-kDa
the infected cells. HeLa cells were infected with VV-hr or VV-36hr with or without
When ZVAD (50 AM) was used, it was added to cells 1 h before infection and rema
with VV-hr and VV-36hr and harvested at various times for immunoblot analysis
total eIF4E. As a positive control for p-eIF4E-specific Abs, HeLa cells were se
harvested for immunoblot analysis.forms a ternary complex with GTP and initiator methionyl-
tRNAi (met-tRNAi) and this complex binds to the 40 S
ribosomal subunit to form the 43 S preinitiation complex.
mRNA binds to the 43 S complex via an eIF4F complex,
comprising eIF4A, eIF4E, and eIF4G, to form the 48 S
preinitiation complex that initiates translation. Previous
studies have shown that the structures of eIF4G, eIF4E,
and eIF2a are frequently altered in apoptotic cells (Gray and
Wickens, 1998; Marissen and Lloyd, 1998; Polunovsky et
al., 2000; Saelens et al., 2001). Besides, viruses are known
to modify eIF4G, eIF4E, and eIF2a to facilitate viral
translation in virus-infected cells (Feduchi et al., 1995; Gale
et al., 2000).
HeLa cells were infected with VV-hr and VV-36hr and
cell lysates were harvested at different times for immunoblot
analysis with antibodies that recognized eIF4G. As shown
in Fig. 5A, VV-hr infection of HeLa cells triggered
significant loss of intact eIF4G of 220-kDa size with the
concomitant appearance of a truncated eIF4G fragment of
100-kDa size at 6–12 h p.i. Cleavage of eIF4G into the 100-eLa cells were infected with VV-hr and VV-36hr and harvested at various
E and probed with an antibody that recognized eIF4G (1:1000). The arrows
cleaved fragments of eIF4G. (B) Caspase-dependent cleavage of eIF4G in
ZVAD (50 AM) and harvested at 10 h p.i. for immunoblot analysis as in (A).
ined throughout the period of the experiments. (C) HeLa cells were infected
with Abs recognizing either the phosphorylated form of eIF4E (p-eIF4E) or
rum-starved overnight, treated with hEGF at 100 ng/ml for 30 min, and
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VV-36hr with slightly more full-length forms of eIF4G
detected at 12 h p.i. Addition of a caspase inhibitor ZVAD
blocked generation of truncated eIF4G, confirming that
cleavage of eIF4G was caspase-dependent (Fig. 5B). The
difference in eIF4G cleavage between VV-hr and VV-36hr
was moderate and thus unlikely to be the cause of viral
translational restriction.
Another component subject to regulation in response to
cellular stress is eIF4E (Gale et al., 2000; Topisirovic et al.,
2003). Phosphorylation of eIF-4E at Ser209 has been
observed in serum-treated cells to correlate with activation
of cellular protein synthesis (Flynn and Proud, 1995). We
therefore analyzed the phosphorylation pattern of eIF4E
Ser209 in cell lysates at different times p.i. No difference
was detected regarding either the phosphorylation status or
the total amount of eIF4E among mock-infected, VV-hr-
infected, or VV-36hr-infected cells (Fig. 5C).
Finally, we investigated the role of eIF2a in the virus-
infected HeLa cells, because the level of phosphorylated
eIF2a is often regarded as an integrated stress sensor for
the arrest of translation initiation in virus-infected cells
(Clemens, 2001; Gale et al., 2000; Kawagishi-Kobayashi
et al., 1997; Yan et al., 2002). Significant phosphoryla-
tion of eIF2a was detected in HeLa cells infected with
VV-hr at 4 and 8 h p.i. (Fig. 6A). Phosphorylation of
eIF2a was detected in HeLa cells infected with VV-36hr,Fig. 6. Investigation of phosphorylation of eIF2a and PKR in HeLa cells infected
infected with VV-hr. HeLa cells were mock-infected (m) or infected with VV-hr or
recognizing phospho-eIF2a (filled arrow head) or total eIF2a (open arrowhead).
HeLa cells were infected as described in A and harvested for immunoblot analys
arrowhead) or total PKR (appears as doublets on gels, marked by an open a
endogenous eIF2a in Hela cells infected with VV-hr. HeLa cells were infected
immunoblot analyses with Abs recognizing phospho-eIF2a (top panel) or total eIF2
from eIF2a-VV or eIF2aS51A-VV-hr that contain a myc tag and, consequently
eIF2aS51A suppresses phosphorylation of endogenous PKR in Hela cells infected
Abs recognizing phospho-PKR (filled triangle) or total PKR (open triangle) as in
eIF2aS51A-VV-hr. HeLa cells were infected with various viruses at a MOI of 5 PF
assays with fluorogenic substrates for caspase-2 and -3 as described in legend ofbut at a reduced level compared to VV-hr. This
observation is interesting and implies a possibility of
phosphorylation of eIF2a in regulation of viral translation
in HeLa cells.
As phosphorylation of eIF2-a by PKR is known to be a
major stress response during viral infections, we inves-
tigated whether PKR was indeed activated in these infected
cells (Fig. 6B) (Gale et al., 1996; Kimball, 1999; Knipe
and Howley, 2001; Saelens et al., 2001). Phosphorylation
of PKR results in slower migration of PKR protein on
SDS-PAGE, i.e., the upper band, whereas unphosphory-
lated PKR runs slightly faster on gel, i.e., the lower band.
Anti-total PKR Ab recognizes both forms so detects PKR
as a doublet on SDS-PAGE (in Fig. 6B, bottom panel).
Anti-phospho-PKR Ab mainly recognizes the phosphory-
lated form (upper band) of PKR with minor cross-
reactivity to the unphosphorylated form (lower band) (in
Fig. 6B, top panel). Mock-infected HeLa cells contained
mostly unphosphorylated PKR, as revealed by the pre-
dominant lower band in immunoblot analyses with an anti-
total PKR Ab (lower panel in Fig. 6B). Phosphorylation of
PKR was readily detected in cells infected with VV-hr,
concomitant with an increased phosphorylation of eIF2a
(compare the upper panels in Fig. 6B with 6A). In HeLa
cells infected with VV-36hr, a reduced level of phosphory-
lated PKR was detected, consistent with less phosphoryl-
ation of eIF2a.with various viruses. (A) Increased phosphorylation of eIF2a in HeLa cells
VV-36hr and harvested at various times for immunoblot analyses with Abs
(B) Increased phosphorylation of PKR in HeLa cells infected with VV-hr.
es with Abs recognizing phospho-PKR (the upper band, marked by a filed
rrowhead). (C) Expression of eIF2aS51A suppresses phosphorylation of
with eIF2a-VV or eIF2aS51A-VV-hr and harvested at various times for
a (bottom panel). The asterisks (*) indicate the exogenous eIF2a expressed
, migrated slower than the endogenous (en) proteins. (D) Expression of
with VV-hr. HeLa cells were infected as described in C, and analyzed with
B. (E) Caspase-2 and -3 activation in HeLa cells infected with eIF2a-VVor
U per cell. Cell lysates were harvested at 8 h p.i. and used in caspase activity
Fig. 4. The experiments were repeated three times.
Fig. 7. eIF2aS51A-VV-hr partially rescues viral translation with moderate
effect on progeny production. (A) Immunoprecipitation of viral intermedi-
ate G8R protein from HeLa cells infected with VV-hr, VV36hr, VV-eIF2a-
VV-hr, or VV-eIF2aS51A-VV-hr. HeLa cells were infected with each virus
and viral proteins were labeled with 35S-methionine at 4–8 h p.i.. Cell
lysates were harvested and immunoprecipitation was performed with an
anti-G8R Ab (1:100) and analyzed on a 10% SDS-PAGE. (B) Radioactive
labeling for viral late protein synthesis in virus-infected HeLa cells. HeLa
cells were either mock-infected (m) or infected with VV-hr, VV-36hr,
eIF2a-VV, or eIF2aS51A-VV-hr. At 10 h p.i., infected cells were starved
for 30 min in methionine-free medium, labeled with 35S-methionine for 1 h,
and harvested for analysis on a 10% SDS-PAGE. Asterisks * mark the
diagnostic cellular protein bands. Black arrowheads indicate viral late
proteins that are present in cells infected with VV-36hr but not in
eIF2aS51A-VV-hr. (C) Virus growth on HeLa cells. HeLa cells were
infected with each virus at a MOI of 1 PFU per cell and cells were harvested
at 48 h p.i. Virus titers in the cell lysates were determined by plaque
formation assays on BHK21 cells. The data were obtained from three
independent and the Y-axis represents the fold increase in virus production
after normalization as described in Materials and methods.
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effect on host restriction whereas inhibition of eIF2a
phosphorylation partially rescued viral gene translation
If phosphorylation of eIF2a or less likely caspase-
dependent cleavage of eIF4G is the cause of host restriction,
reversal of one of these events should mimic the function of
the CP77 gene and rescue virus growth. To examine the role
of eIF4G on viral translation, cells were infected with VV-hr
and incubated with ZVAD to block eIF4G cleavage; however,
no translation of G8R protein could be detected and no virus
progeny was produced (data not shown). To examine the role
of phosphorylation of eIF2a in host restriction, we con-
structed recombinant viruses derived from VV-hr expressing
either wild-type eIF2a or a mutant eIF2a containing single
serine to alanine mutation at amino acid position 51 (S51A),
which interferes with phosphorylation of eIF2a (Kramer,
1990; Murtha-Riel et al., 1993; Price et al., 1991). Both
recombinant viruses expressed abundant levels of eIF2a
protein that migrated slower than the endogenous protein, due
the presence of a myc tag at the C-terminus (Fig. 6C) (Saelens
et al., 2001). Furthermore, expression of the eIF2aS51A
mutant, but not wild-type eIF2a, suppressed phosphorylation
of endogenous eIF2a in the infected cells. Finally, we also
found that expression of the eIF2aS51Amutant, but not wild-
type eIF2a suppressed phosphorylation of endogenous PKR
in the infected cells at 4 h p.i. (Fig. 6D). This result was
unexpected and suggested a feedback regulation of eIF2a
phosphorylation on PKR activation.
To determine whether expression of eIF2aS51A sup-
presses apoptosis, we measured caspase activation in HeLa
cells infected with VV-hr, eIF2aVV-hr, or eIF2aS51A-VV-
hr at 8 h p.i. (Fig. 6E). Consistent with Fig. 4, VV-hr
infection induced 3–4-fold increase of caspase-2 and -3
activities and expression of WT-eIF2a or eIF2aS51A
reduced caspase activities to a similar level with VV-36hr
(shown in Fig. 4). Therefore, modulation of eIF2a and its
phosphorylation status could influence cellular apoptotic
response in HeLa cells infected with VV-hr.
Because eIF2aVV-hr and eIF2aS51A-VV-hr suppressed
caspase activation, we then investigated whether viral
translation is resumed in these cells. HeLa cells were
infected with VV-hr, VV-36hr, eIF2aVV-hr, or eIF2aS51A-
VV-hr and synthesis of the viral intermediate G8R protein
was monitored by immunoprecipitation of 35S-methionine-
labeled cell lysates with an Ab recognizing a synthetic G8R
peptide (Fig. 7A). Cells infected with VV-36hr expressed
the intermediate G8R protein that was not detected in cells
infected with VV-hr. Overexpression of wild-type eIF2a did
not induce G8R protein synthesis. In contrast, in cells
infected with eIF2aS51A-VV-hr, synthesis of the G8R
protein became detectable, suggesting that phosphorylation
of eIF2a contributes to suppression of viral intermediate
gene translation in HeLa cells infected with VV-hr. In
another experimental approach, inhibition of eIF4G cleav-
age was combined with suppression of phosphorylation of
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eIF2aS51A-VV. Addition of ZVAD had no additive effect
on viral G8R protein synthesis in cells infected with VV-hr-
eIF2aS51A-VV (data not shown).
Synthesis of viral late proteins was also examined in
HeLa cells infected with VV-hr, VV-36hr, eIF2aVV-hr, or
eIF2aS51A-VV by 35S-methionine labeling at 8 h p.i. (Fig.
7B). As expected, abundant late viral protein synthesis was
detected in cells infected with VV-36hr but not with VV-hr.
Moreover, increased late viral protein synthesis was also
detected in cells infected with eIF2aS51A-VV-hr, consistent
with the increased level of G8R protein observed in Fig. 7A.
It is worth noting that some of the strong viral late proteins
remained missing in the presence of eIF2aS51A (arrow-
heads in Fig. 7B), indicating that phosphorylation of eIF2a
may only regulate translation of some but not all viral late
protein synthesis in cells.
Finally, we tested whether partial recovery of viral
translation in HeLa cells infected with eIF2aS51A-VV-hr
could lead to increased production of infectious virions.
HeLa cells were infected with each virus at a MOI of 1 PFU
per cell and virus multiplication was monitored at 48 p.i.
(Fig. 7C). VV-hr did not grow and was used as the negative
control. EIF2a-VV-hr also did not grow within 48 h p.i. VV-
36hr, on the other hand, grew more than 100-fold (data not
shown). Virus titers of eIF2aS51A-VV-hr only showed a
moderate increase of 5-fold at 48 h p.i., indicating that a full
relief of viral translation restriction in restrictive HeLa cells
requires participation of additional cellular factors that are
targeted by CP77.Discussion
In this paper, we have demonstrated that a host range
mutant virus, VV-hr, could transcribe, but not translate,
viral intermediate genes in HeLa cells. Expression of the
cowpox virus CP77 gene from a recombinant VV-36hr
suppressed apoptosis and rescued virus translation. Upon
infection with VV-hr, HeLa cells display morphological
and biochemical features of apoptosis. Furthermore, we
found that VV-hr triggered PKR activation and phosphor-
ylation of eIF2a and that CP77 expression suppressed both
events. Inhibition of eIF2a phosphorylation reduced both
PKR activation and caspase activities prompted us to test
out our hypothesis that whether phosphorylation of eIF2a
acts as the sensor not only for cellular stress but also for
viral translation in cells. Our results with eIF2aS51A
mutant showed that viral translation blockage in VV-hr
could be partially relieved when phosphorylation of eIF2a
in cells was suppressed, indicating a role of eIF2a in viral
translation. However, the status of eIF2a may only be
important for a subset of viral genes and is not sufficient to
rescue viral infectivity from restrictive HeLa cells. There-
fore, we rationalize that CP77 must act on upstream of
eIF2a, caspase, and PKR activation, to justify its influenceon additional molecules involving viral translation and host
restriction. Our study is limited in HeLa cells and whether
our results may be of use for CHO and RK13 cells
remains to be determined.
Identification of caspase-2 and capspase-3 activation in
HeLa cells after viral DNA replication raised the possi-
bility that caspases could cleave important cellular or viral
factors necessary for viral translation. Currently, there have
been no reports of viral proteins acting as caspase
substrates except for crmA, which is a direct inhibitor of
caspases (Gagliardini et al., 1994; Komiyama et al., 1994;
Zhou et al., 1997). In contrast, caspase-dependent cleavage
of eIF4G was found in cells infected with VV-hr and VV-
36hr. However, such cleavage is unlikely to be the cause
of the viral translation defect because the difference was
small between VV-hr and VV-36hr as well as inhibition of
caspase-dependent cleavage of eIF4G did not restore viral
translation. Therefore, we did not find any data arguing an
indispensable role of intact eIF4G in viral translation, a
conclusion consistent with that proposed by Mulder et al.
(1998). Could other caspase substrates be important for
host restriction? It is difficult to assess whether cleavage of
any specific substrate contributes to host restriction.
However, our data with pan-caspase inhibitors, such as
ZVAD and Boc-D, suggested that inhibition of caspase
activity in HeLa cells did not relieve viral translation (data
not shown). Besides, expression of E1B19K has been
shown to block FADD-mediated caspase 8 activation, but
fails to rescue viral growth in CHO cells (Ink et al., 1995).
Likewise, expression of bcl-2, known to block mitochon-
dria-mediated caspase-9 activation, did not relieve host
restriction in CHO cells (Chung et al., 1997). It is thus
unlikely that activation of caspase cascades per se could
explain host restriction but we could not completely
exclude this possibility.
We were surprised to detect PKR activation in VV-hr
infected HeLa cells because VV-hr was derived from the
Copenhagen strain of vaccinia virus and, consequently,
should contain E3L and K3L genes, both of which are
known to antagonize PKR functions and down-regulate
eIF2a phosphorylation (Beattie et al., 1995a, 1995b). We
have cloned and sequenced the endogenous E3L and K3L
genes from VV-hr and VV-36hr. The sequences proved
identical to the ORF of the published WR strain except for
two changes at aa 74 and 75, from EA to KP, which are the
natural Copenhagen sequences (Goebel et al., 1990). It
therefore appeared that these genes are intact in VV-hr and
VV-36hr viral genomes and the changes do not account for
PKR activation in the infected cells. Another mechanism for
PKR activation has been described in apoptotic cells in
which caspase-dependent cleavage of PKR at residue D251
leads to phosphorylation of eIF2a and translation inhibition
(Saelens et al., 2001). Although it is an attractive hypothesis
to explain PKR activation, we found no evidence for such a
cleavage form of PKR present in the VV-hr infected HeLa
cells. A third possibility could be the deregulation of
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PKR and eIF2a (Brush et al., 2003) and this issue will be
investigated in the future.
Translation of vaccinia virus genes appears compli-
cated due to several issues: First, vaccinia virus shuts off
host protein synthesis in the infected cells. In some cases,
shut off is mediated through a virion-associated protein
but in other cases viral early gene expression is required
(Drillien et al., 1978; Moss, 1968; Person and Beaud,
1978). Although inhibition of the formation of 40 S-Met-
tRNAMet initiation complex and disintegration of poly-
ribosomes in vaccinia virus-infected cells have been
described, up to now, a detailed mechanism for host
protein shut off is not established (Damaso and Mous-
satche, 1992; Jefferts and Holowczak, 1971; Person et al.,
1980). Unlike picornaviruses, which transcribe RNA
containing internal ribosome entry site (IRES) elements
to trap ribosomes for translation initiation, vaccinia virus
RNA does not contain any elaborate stem-and-loop RNA
structure and little is known about the cis-acting viral
RNA elements that are important for viral translation in
cells. It is also not known whether translation complexes
for viral early, intermediate and late genes are identical or
not. There are two modes that CP77 may use to rescue
viral translation in cells. CP77 could either function as a
component of a viral translation complex in these cells.
Alternatively, CP77 may regulate upstream signals to
influence translation indirectly. We have tentatively
assigned CP77 as being upstream of caspase and PKR
activation since our data support such a regulatory role
for CP77.
From our results, we also expect that there should be
additional cellular targets that are regulated by CP77 to
relieve translational restriction in these cells. A number of
reports suggest that during rapid apoptosis, shutdown of
protein synthesis occurs at multiple levels (Marissen et
al., 2000; Nadano and Sato, 2000; Polunovsky et al.,
2000). Future studies may reveal to us that control of
translation plays a major role in the cell death processes,
at the same time providing cells with an antiviral strategy.
Identification of additional cellular targets regulated by
CP77 will be important for our understanding of poxvirus
host restriction.Materials and methods
Cell cultures, viruses, and reagents
HeLa cells were cultured in DMEM supplemented
with 10% fetal bovine serum (FBS). BSC40 cells cultured
in DMEM supplemented with 10% calf serum and
BHK21 cells were cultured in RPMI with 10% FBS.
Cordecepin (CP), cycloheximide (CHX), and cytosine
arabinoside (araC) were purchased from Sigma Inc.
Fluorogenic substrates for caspase-1, -2, -3, -8, and -9were purchased from AnaSpec Inc. VV-Isolation of VV-hr
has been described previously (Drillien et al., 1981). VV-
hr has an 18-kbp deletion of the viral genome that
overlaps two genes designated K1L and C7L, known to
be essential for VV multiplication in various human cell
lines (Gillard et al., 1986; Goebel et al., 1990; Oguiura et
al., 1993). VV-36hr was obtained from Dr. R. Drillien
and constructed from VV-hr through an intermediate
construct, VV-hr ts38, by insertion into its thymidine
kinase locus of a cowpox virus gene, designated CP77,
which enables virus multiplication in CHO cells. One
recombinant isolate designated VV-36hr was plaque-
purified several times and used for further studies as
described (Drillien et al., 1982; Spehner et al., 1988).
Antibodies against PKR and eIF2a were purchased from
Santa Cruz, Inc. Antibodies against the phospho-PKR
(Thr 446) and phospho-eIF2a (Ser 51) were from Cell
Signaling and Stressgen Inc., respectively. Antibodies
against F17R protein were a gift from Dr. Jacomine
Krise-Locker. Rabbit anti-G8R antiserum was generated
from a synthetic peptide bQKKSYVFNFHKYEEKQ
derived from G8R sequences (Bravo Inc., Taiwan).
Generation of eIF2a-VV-hr and S51A-eIF2a-VV-hr
Plasmids containing human wt-eIF2a (pEF6-eIF2-A-
myc-His), S51A-eIF2a (pEF6-eIF2-A-S51A-Myc-His)
DNA were previously described and obtained from the
public BCCM/LMBP collection (LMBP collection no.
4506/4505) (Saelens et al., 2001). The plasmids were
digested with BamHI, blunt-ended, and then digested with
Pmel. The cDNA inserts were subsequently cloned into a
SmaI-digested pSC11-360 vector that contained synthetic
early promoter sequences from vMJ360 (AAAAATT-
GAAAAATTAGCT), replacing the original p7.5K pro-
moter for foreign gene expression (Davison and Moss,
1989). These plasmids were designated pSC11-360-wt-
eIF2a and pSC11-360-S51A-eIF2a, respectively. BHK21
cells (1  106 cells/100 mm) were infected with VV-hr at
a MOI of 0.1 PFU/cell and subsequently transfected with
the aforementioned plasmids (3 Ag in 60 Al lipofectamine)
for 2.5 h. Cells were washed and cultured in normal
medium and harvested at 3 days p.i. The cell lysates were
collected and titrated for recombinant virus plaque
isolation on BHK21 cells under 1% top agarose with X-
gal (150 Ag/ml) staining for lacZ expression. Blue plaques
were picked and recombinant viruses were subsequently
plaque purified three times until reaching 100% purity.
One-step growth curve analysis
HeLa cells were infected with VV-hr or VV-36hr at a
MOI of 5 PFU per cell at 378C for 1 h. Cells were incubated
in normal medium and harvested at 0 and 24 h p.i. Virus
titers were determined on BHK21 cells using plaque assays
as described above.
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Viral DNA replication was detected using a modification
from a previously published method (Seto et al., 1987). In
brief, HeLa cells were infected withWT-VV, VV-hr, and VV-
36hr at a MOI of 10 PFU per cell and harvested at various
times (0, 1, 2, 3, 4, and 6 h) p.i. Cells were washed in PBS and
lysed with digestion buffer (100 mM NaCl, 10 mM Tris–Cl
pH 8, 25 mM EDTA pH 8, 0.5% SDS). The lysates were
digested with proteinase K (100 Ag/ml), extracted with
phenol–chloroform, and total DNA was isolated by isopro-
panol precipitation. After RNase treatment, DNA samples
were applied to nitrocellulose paper using a microsample
filtration manifold (Schleicher & Schuell, Inc.). The filters
were hybridized with a 32P-labeled VGF DNA fragment,
washed, and autoradiographed. The experiments were
repeated twice, and the resulting blots were scanned,
quantitated and averaged with a phosphoimager (Molecular
Dynamics, Inc.).
Radioactive amino acid labeling for viral protein synthesis
HeLa cells were mock-infected or infected with VV-hr or
VV-36hr at a MOI of 10 PFU per cell and cultured in
DMEM+ 10% FBS. At various times (0, 1, 2, 3, 4, 6, and 8 h)
p.i., cells were starved in methionine-free DMEM medium
for 30 min and labeled with 35S-methionine-containing
medium (100 ACi/ml) for 1 h. Cells were subsequently
washed with PBS and lysed with SDS-containing sample
buffer. Lysates were separated on 10% SDS-PAGE and the
levels of viral protein synthesis were determined by the
presence of diagnostic late protein bands on autoradiograms.
Alternatively, HeLa cells were infected with VV-hr, VV-36hr,
eIF2a-VV-hr, or eIF2aS51A-VV-hr at a MOI of 10 PFU per
cells, starved in methionine-free DMEMmedium for 30 min,
pulse-labeled for 1 h at 10 h p.i., and immediately harvested.
The cell lysates were separated on 10% SDS-PAGE, dried,
and autographed.
To immunoprecipitate viral intermediate G8R protein,
HeLa cells were infected with VV-hr, VV36hr, VV-eIF2a-
VV-hr, or VV-eIF2aS51A-VV-hr at a MOI of 10 PFU per
cell. Cells were starved for 30 min and subsequently
labeled with 35S-methionine (100 ACi/ml) at 4–8 h p.i. Cell
lysates were harvested and immunoprecipitation was
performed with an anti-G8R Ab (1:100) at 48C for 60
min and protein A beads were added for an additional 60-
min incubation, washed, and analyzed on a 10% SDS-
PAGE.
Northern blot analysis
HeLa cells were infected as described and harvested at
0.5, 1, 2, 4, 6, and 8 h p.i. Total RNA was isolated with a
Qiagene RNeasy minikit, separated on a 1% formaldehyde
agarose gel, transferred to nitrocellulose paper and hybri-
dized with a 32P-labeled G8R or F17R PCR DNA fragment,washed, and autoradiographed as described (Baldick and
Moss, 1993).
Immunoblot analysis
HeLa cells were infected with VV-hr or VV-36hr at a
MOI of 5 PFU per cell and cell lysates were harvested at
various time points after infection. Whole cell extracts
were fractionated by SDS-PAGE and transferred to a
nitrocellulose membrane using a transfer apparatus accord-
ing to the manufacturer’s protocol (BioRad). After
incubation with 0.2% I-block (Applied Biosystems Inc.)
in PBST (1 PBS/0.1% Tween-20) for 60 min, the
membrane was incubated with each primary antibody at
room temperature for 60 min (for G8R-, F17R-, PKR-
specific Abs) or at 48C overnight (for phospho-PKR,
phospho-eIF2a, phospho eIF4E, eIF2a-, eIF4E-, eIF4G-
specific Abs). Membranes were washed five times for 5
min with PBST and incubated with a 1:2000 dilution of
alkaline phosphatase-conjugated goat anti-mouse (Pierce
Inc.) or 1:2000 goat anti-rabbit (NEB) secondary antibody
for 120 min. Blots were washed with PBST for five times
and developed with CDP-Star (Applied Biosystems Inc.)
as described by the manufacturer.
Caspase activity assays
The caspase assays were performed according to the
fluorometric CaspACEk Assay system (Promega, Inc.). In
brief, HeLa cells were seeded at 1.2  106/100 mm and
infected with VV-hr or VV-36hr at a MOI of 5 PFU per
cell. Cell lysates were harvested at 8 h p.i., freeze–thawed
four times, and centrifuged to remove nuclei. Soluble cell
lysates were saved and equal amounts of cellular proteins
were used in caspase activity assays with fluorogenic
substrates for caspase-1, -2, -3, -8, and -9 in caspase assay
buffer [312.5 mM HEPES (pH 7.5)/31.25% sucrose/
0.3125% CHAPS] as described in the manufacturer’s
manuals. Fluorescence was measured with a spectrofluor-
ometer, using an excitation wavelength of 360 nm and an
emission wavelength of 460 nm.
Growth of eIF2a-VV-hr and eIF2aS51A-VV-hr on HeLa
cells
HeLa cells were infected with VV-hr, VV-36hr, eIF2a-
VV-hr, or eIF2aS51A-VV-hr at a MOI of 1 PFU per cell
and cells were harvested at 48 p.i. Virus titers in the cell
lysates were determined by plaque formation assays on
BHK21 cells. The data were obtained from three inde-
pendent experiments with standard deviations. The Y-axis
represents the fold increase of virus production, as
calculated using the following equation = [Titers of virus
of interest at 48 h p.i. / Titers of virus of interest at 0 h
p.i.] / [Titers of VV-hr at 48 h p.i. / Titers of VV-hr at 0 h
p.i.].
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